These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 18480585)

  • 1. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
    Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
    Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
    Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
    Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of FDG-PET to diagnose intravascular lymphomatosis presenting as fever of unknown origin.
    Hoshino A; Kawada E; Ukita T; Itoh K; Sakamoto H; Fujita K; Mantani N; Kogure T; Tamura J
    Am J Hematol; 2004 Jul; 76(3):236-9. PubMed ID: 15224358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
    Wagner T; Brechemier D; Dugert E; Le Guellec S; Julian A; Hitzel A; Beyne-Rauzy O
    Cancer Imaging; 2012 Jan; 12(1):7-12. PubMed ID: 22275725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary bone marrow diffuse large B-cell lymphoma affecting distal parts of the legs as a cause of persisting B symptoms.
    Lapa C; Knott M; Rasche L; Herrmann K; Buck AK; Rosenwald A
    Eur J Haematol; 2014 Dec; 93(6):545-6. PubMed ID: 24612353
    [No Abstract]   [Full Text] [Related]  

  • 6. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma.
    Stewart DA; Kloiber R; Owen C; Bahlis NJ; Duggan P; Mansoor A; Bence-Bruckler I
    Leuk Lymphoma; 2014 Sep; 55(9):2064-70. PubMed ID: 24188476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of FDG-PET/CT for the diagnosis of intravascular large B-cell lymphoma presenting with fever of unknown origin and renal dysfunction].
    Yago K; Yanagita S; Aono M; Matsuo K; Shimada H
    Rinsho Ketsueki; 2009 Jun; 50(6):499-502. PubMed ID: 19571511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in Advanced-stage diffuse large B-Cell lymphoma.
    Moskowitz CH; Schöder H; Teruya-Feldstein J; Sima C; Iasonos A; Portlock CS; Straus D; Noy A; Palomba ML; O'Connor OA; Horwitz S; Weaver SA; Meikle JL; Filippa DA; Caravelli JF; Hamlin PA; Zelenetz AD
    J Clin Oncol; 2010 Apr; 28(11):1896-903. PubMed ID: 20212248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diffuse large B-cell lymphoma relapsing with intravascular large B-cell lymphoma-like perivascular and intravascular lesions].
    Ishikawa T; Fukumi T; Moriyama T; Murakami H; Nagakita K; Yoshioka T; Makita M; Shinno Y; Sunami K
    Rinsho Ketsueki; 2019; 60(10):1455-1461. PubMed ID: 31695007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis.
    Adams HJ; Nievelstein RA; Kwee TC
    Br J Haematol; 2015 Jul; 170(2):185-91. PubMed ID: 25833790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain glucose metabolism in diffuse large B-cell lymphoma patients as assessed with FDG-PET: impact on outcome and chemotherapy effects.
    Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
    Acta Radiol; 2016 Jun; 57(6):733-41. PubMed ID: 26297729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravascular Large B-cell Lymphoma: a Clinical Analysis of 17 Cases].
    Yang JJ; Chen XC; Tang Y; Shen K; Xie LP; Liu T
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):145-147. PubMed ID: 29737107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravascular large B-cell lymphoma: an important cause of fever of unknown origin].
    Masaki Y; Miki M; Sakai T; Sawaki T; Fukushima T; Umehara H
    Brain Nerve; 2011 May; 63(5):435-41. PubMed ID: 21515922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmental tandem triplication of the MLL gene in an intravascular large B-cell lymphoma with multisystem involvement: a comprehensive morphologic, immunophenotypic, cytogenetic, and molecular cytogenetic antemortem study.
    Deisch J; Fuda FB; Chen W; Karandikar N; Arbini AA; Zhou XJ; Wang HY
    Arch Pathol Lab Med; 2009 Sep; 133(9):1477-82. PubMed ID: 19722759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular Large B-Cell Lymphoma Complicated by Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis that was Successfully Treated with Rituximab-Containing Chemotherapy.
    Tsuda M; Nakashima Y; Ikeda M; Shimada S; Nomura M; Matsushima T; Takahashi S; Aishima S; Oda Y; Shiratsuchi M; Takayanagi R
    J Clin Exp Hematop; 2015; 55(1):39-43. PubMed ID: 26106006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of interim ¹⁸F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphoma.
    Yang DH; Min JJ; Song HC; Jeong YY; Chung WK; Bae SY; Ahn JS; Kim YK; Bom HS; Chung IJ; Kim HJ; Lee JJ
    Eur J Cancer; 2011 Jun; 47(9):1312-8. PubMed ID: 21334197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab.
    Kusaba T; Hatta T; Tanda S; Kameyama H; Tamagaki K; Okigaki M; Inaba T; Shimazaki C; Sasaki S
    Clin Nephrol; 2006 Mar; 65(3):222-6. PubMed ID: 16550755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and treatment outcomes of intravascular large B-cell lymphoma: a single-center experience in Korea.
    Hong JY; Kim HJ; Ko YH; Choi JY; Jung CW; Kim SJ; Kim WS
    Acta Haematol; 2014; 131(1):18-27. PubMed ID: 24021554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.